Insider Transactions in Q2 2024 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2024
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+11.09%
|
-
|
|
Jun 06
2024
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+11.59%
|
-
|
|
Apr 19
2024
|
Ira Duarte EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,122
-1.26%
|
$2,244
$2.64 P/Share
|
|
Apr 19
2024
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+4.18%
|
-
|
|
Apr 19
2024
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+4.47%
|
-
|
|
Apr 19
2024
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,797
+4.99%
|
-
|
|
Apr 03
2024
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+20.06%
|
-
|